Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei Mei

Showing results (731-740 of 760) with videos related to

Pageof 76
Sort By:
Endocrine|June 12, 2023
Iodine status and its association with prevalence of thyroid diseases in adults from Jiangxi Province, ChinaDi-En Yan, Lei Hu, Yun-Feng Shen, et al.
Nature Medicine|September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinomaDaniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Diabetes Care|May 31, 2020
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled TrialSue A Brown, Roy W Beck, Dan Raghinaru, et al.
Nature Metabolism|June 23, 2021
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19Sin Man Lam, Chao Zhang, Zehua Wang, et al.
Nature Communications|September 19, 2019
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphomaZhaoming Li, Xudong Zhang, Weili Xue, et al.
Molecular Oncology|April 20, 2023
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapyHai-Yan Tu, Kai Yin, Xiaotian Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targetsMing Liu, Qian Yan, Yi Sun, et al.
Genome Medicine|October 12, 2021
Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancerTaotao Sheng, Shamaine Wei Ting Ho, Wen Fong Ooi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.
F1000Research|February 1, 2024
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impactStefan Jungbluth, William Martin, Monika Slezak, et al.
Pageof 76

Showing results (731-740 of 760) with videos related to

Sort By:
Pageof 76
Endocrine|June 12, 2023
Iodine status and its association with prevalence of thyroid diseases in adults from Jiangxi Province, ChinaDi-En Yan, Lei Hu, Yun-Feng Shen, et al.
Nature Medicine|September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinomaDaniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Diabetes Care|May 31, 2020
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled TrialSue A Brown, Roy W Beck, Dan Raghinaru, et al.
Nature Metabolism|June 23, 2021
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19Sin Man Lam, Chao Zhang, Zehua Wang, et al.
Nature Communications|September 19, 2019
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphomaZhaoming Li, Xudong Zhang, Weili Xue, et al.
Molecular Oncology|April 20, 2023
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapyHai-Yan Tu, Kai Yin, Xiaotian Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targetsMing Liu, Qian Yan, Yi Sun, et al.
Genome Medicine|October 12, 2021
Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancerTaotao Sheng, Shamaine Wei Ting Ho, Wen Fong Ooi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.
F1000Research|February 1, 2024
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impactStefan Jungbluth, William Martin, Monika Slezak, et al.
Pageof 76